SCHEMBL6587982

SCHEMBL6587982

CC=CC(=O)Nc1ccc(C)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NMT1 P30419 1/20 0.70
▸ DDAH1 O94760 1/20 0.68
▸ TGM2 P21980 1/20 0.63
▸ MMP1 P03956 4/20 0.62
▸ MMP2 P08253 4/20 0.62
▸ MMP9 P14780 4/20 0.62
▸ EGFR P00533 1/20 0.62
▸ ALDH1A1 P00352 2/20 0.60
▸ LMNA P02545 2/20 0.57
▸ MAPT P10636 2/20 0.55
▸ TP53 P04637 1/20 0.55
▸ THRB P10828 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ POLB P06746 2/20 0.53
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ HTT P42858 3/20 0.51
▸ MTNR1A P48039 1/20 0.51
▸ MTNR1B P49286 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26034043 1.00 NMT1 (0.70) NMT1DDAH1TGM2MMP1MMP2
SCHEMBL14578749 0.90 NMT1 (0.85) NMT1DDAH1TGM2MMP1MMP2
SCHEMBL5175946 0.84 MAPT (0.67) NMT1MMP1MMP2MMP9ALDH1A1
SCHEMBL3200856 0.84 MAPT (0.67) NMT1MMP1MMP2MMP9ALDH1A1
SCHEMBL5177468 0.82 NMT1 (1.00) NMT1DDAH1TGM2MMP1MMP2
SCHEMBL20280569 0.82 TGM2 (0.67) NMT1DDAH1TGM2LMNAMAPT
SCHEMBL29246294 0.82 TGM2 (0.61) NMT1DDAH1TGM2MMP1MMP2
SCHEMBL31501449 0.82 MAPT (0.55) NMT1DDAH1MMP1MMP2MMP9
SCHEMBL15217981 0.82 NMT1 (0.73) NMT1DDAH1TGM2MMP1MMP2
SCHEMBL5177395 0.82 NMT1 (1.00) NMT1DDAH1TGM2MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1186601-B1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMA CO LTD (JP) 2004-03-24 — — EP disclosed
US-6573279-B1 Drug, particularly to a novel isoquinoline derivative or its salt having an If current inhibitory effect without serious side effects such as convulsion and also to a drug, particularly a cardiac rate lowering agent, containing the ASTELLAS PHARMA INC. (JP) 2003-06-03 — — US disclosed
EP-1186601-A1 NOVEL ISOQUINOLINE DERIVATIVES OR SALTS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2002-03-13 — — EP disclosed
Send feedback